An epidemiological review of systemic fungal infections

Journal de Mycologie Medicale

Volumn 12, Issue 4, 2002, Pages 163-173

  Dupont, B ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Aspergillus; Candida; Diagnosis; Epidemiology; Immunocompromised host; Risk factor

Indexed keywords

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BURN; CANDIDA ALBICANS; CANDIDIASIS; CATHETER INFECTION; CHRONIC GRANULOMATOUS DISEASE; COCCIDIOIDES; CRYPTOCOCCUS; CRYPTOCOCCUS NEOFORMANS; DNA HYBRIDIZATION; HEMATOLOGIC DISEASE; HIGH RISK POPULATION; HISTOPLASMA; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INCIDENCE; INFECTION RISK; INFECTION SENSITIVITY; KARYOTYPING; LUNG DISEASE; MOLECULAR BIOLOGY; MORBIDITY; MORTALITY; MYCOSIS; NEUTROPENIA; PENICILLIUM MARNEFFEI; PNEUMOCYSTIS CARINII; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW;

AJELLOMYCES; ASPERGILLUS; ASPERGILLUS FUMIGATUS; CANDIDA; CANDIDA ALBICANS; COCCIDIOIDES; FILOBASIDIELLA NEOFORMANS; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS; PENICILLIUM; PENICILLIUM MARNEFFEI; PNEUMOCYSTIS CARINII;

EID: 0036915503     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (133)

1. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997;24: 1122-8 (erratum in Clin Infect Dis 1997;25:352).
2. Anadol D, Ozcelik U, Kiper N, Gocmen A. Allergic bronchopulmonary aspergillosis in two patients with cystic fibrosis. Turkish J Ped 2000;42:68-71.
3. Anaissie EJ, Costa S. FNosocomial aspergillosis is waterborne. Clin Infect Dis 2001;33:1546-8.
4. Ashley MV, Dow BD. The use of microsatellite analysis in population biology: Background, methods and potential applications. EXS 1994;69:185-201.
5. Aufauvre-Brown A, Cohen J, Holden DW. Use of randomly amplified polymorphic DNA markers to distinguish isolates of Aspergillus fumigatus. J Clin Microb 1992;30:2991-3.
6. Beck-Sague C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993;167: 1247-51.
7. Becker WK, Cioffi WGJ, McManus AT, et al. Fungal burn wound infection. A 10-years experience. Arch of Surg 1991;126:44-8.
8. Bodey G, Bueltmann B, Duguid W, et al. Fungal infections in cancer patients: An international autopsy survey. Europ J Clin Microb Infect Dis 1992;11:99-109.
9. Borzotta AP, Beardsley K. Candida infections in critically ill trauma patients: A retrospective case-control study. Archiv Surg 1999;134:57, 664-5.
10. Botterel F, Desterke C, Costa C, Bretagne S. Analysis of microsatellite markers of Candida albicans used for rapid typing. J Clin Microb 2001;39:4076-81.
11. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years' experience at a cancer center and implications for management. Blood 1997;90:999-1008.
12. Brooks RG, Hofflin JM, Jamieson SW, Stinson EB, Remington JS. Infectious complications in heart-lung transplant recipients. Am J Med 1985;79:412-22.
13. Bross J, Talbot GH, Maislin G, Hurwitz S, Strom BL. Risk factors for nosocomial candidemia: A case-control study in adults without leukemia. Am J Med 1989;87:614-620.
14. Cano MI, Cisalpino PS, Galindo I, Ramirez JL, Mortara RA, da Silveira JF. Electrophoretic karyotypes and genome sizing of the pathogenic fungus Paracoccidioides brasiliensis. J Clin Microb 1998; 36:742-7.
15. Carlotti A, Chaib F, Couble A, Bourgeois N, Blanchard V, Villard J. Rapid identification and fingerprinting of Candida krusei by PCR-based amplification of the species-specific repetitive polymorphic sequence CKRS-1. J Clin Microb 1997;35:1337-43.
16. Carlotti A, Couble A, Domingo J, Miroy K, Villard J. Species-specific identification of Candida krusei by hybridization with the CkF1, 2 DNA probe. J Clin Microb 1996;34:1726-31.
17. Chapman SW, Lin AC, Hendricks KA, et al. Endemic blastomycosis in Mississippi: Epidemiological and clinical studies. Semi Resp Inf 1997;12:219-28.
18. Chen F, Currie BP, Chen LC, Spitzer SG, Spitzer ED, Casadevall A. Genetic relatedness of Cryptococcus neoformans clinical isolates grouped with the repetitive DNA probe CNRE-1. J Clin Microb 1995;33:2818-22.
19. Cimon B, Carrere J, Vinatier JF, Chazalette JP, Chabasse D, Bouchara JP. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Europ J Clin Microb Inf Dis 2000;19:53-6.
20. Cobb BD, Clarkson JM. A simple procedure for optimising the polymerase chain reaction (PCR) using modified Taguchi methods. Nucl Ac Res 1994;22:3801-5.
21. Cohen MS, Isturiz RE, Malech HL, et al. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med 1981;71:59-66.
22. Coleman DC, Bennett DE, Sullivan DJ, et al. Oral Candida in HIV infection and AIDS: New perspectives/new approaches. Crit Rev Microb 1993;19:61-82.
23. Currie BP. Impact of antimicrobial use on the epidemiology of nosocomial infections on the oncology ward: Implications for infection control. Canc Invest 1998;16:263-8.
24. Dankner WM, Spector SA, Fierer J, Davis CE. Malassezia fungemia in neonates and adults: Complication of hyperalimentation. Rev Infecf Dis 1987;9:743-53.
25. Dauber JH, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med 1990;11:291-308.
26. Deitch E. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1990;125:403-4.
27. Deitel M, Kaminsky VM, Fuksa M. Growth of common bacteria and Candida albicans in 10% soybean oil emulsion. Can J Surg 1975;18:531-5.
28. Delmotte F, Leterme N, Simon JC. Microsatellite allele sizing: Difference between automated capillary electrophoresis and manual technique. Biotech 2001;31:810, 814-6, 818.
29. Drutz D. Fungal infections. Cur Op Infect Dis 1989;2:227.
30. Dummer JS, Hardy A, Poorsattar A, Ho M. Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transpl 1983;36:259-67.
31. Dummer JS, Montero CG, Griffith BP, Hardesty RL, Paradis IL, Ho M. Infections in heart-lung transplant recipients. Transpl 1986;41:725-9.
32. Eccles NK, Scott GM. Aspergillus in pepper. Lancet 1992;339:618.
33. Elias Costa MR, Carnovale S, Relloso MS. Oropharyngeal candidosis in AIDS patients: An epidemiological study using restriction analysis of Candida albicans total genomic DNA. Myc 1999;42:41-6.
34. Faix RG. 1992 Invasive neonatal candidiasis: Comparison of albicans and parapsilosis infection. Ped Infect Dis J 11:88-93.
35. Fanquet T, Muller N, Gimenez A, Domingo P, Plaza V, Bordes R. Semiinvasive pulmonary aspergillosis in chronic obstructive pulmonary disease: Radiologic and pathologic findings in nine patients. Am J Roentgen 2000;174:51-6.
36. Fraser DW, Ward JI, Ajello L, Plikaytis BD. Aspergillosis and other systemic mycoses. The growing problem. JAMA 1979;242:1631-5.
37. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microb Rev 1996;9:499-511.
38. Geller DE, Kaplowitz H, Light MJ, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: Reported prevalence, regional distribution, and patient characteristics. Chest 1999;116:639-46.
39. Giamarellou H, Antoniadou A. Epidemiology, diagnosis, and therapy of fungal infections in surgery. Infect. Cont Hosp Epidem 1996;17:558-64.
40. Girardin H, Sarfati J, Kobayashi H, Bouchara JP, Latge JP. Use of DNA moderately repetitive sequence to type Aspergillus fumigatus isolates from aspergilloma patients. J Infect Dis 1994;169:683-5.
41. Glasmacher A, Hahn C, Molitor E, Sauerbruch T, Schmidt-Wolf IG, Marklein G. Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukemia. Mycoses 1999;42:395-402.
42. Gottfredsson M, Cox GM, Perfect JR. Molecular methods for epidemiological and diagnostic studies of fungal infections. Pathology 1998;30:405-18.
43. Gozdasoglu S, Ertem M, Buyukkececi Z, et al. Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy. Med Ped Onc 1999;32:344-8.
44. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nübling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996;33:23-32.
45. Grosse G, Staib F, Rapp J, Rang H, Heise W, Kaufman L. Pathological and epidemiological aspects of skin lesions in histoplasmosis. Observations in an AIDS patient and badgers outside endemic areas of histoplasmosis. Zentralblatt fuer Bakteriologie 1997;285:531-9.
46. Gumbo T, Isada CM, Hall G, Karafa MT, Gordon SM. Candida glabrata fungemia. Clinical features of 139 patients. Medicine (Baltimore) 1999;78:220-7.
47. Haase G, Skopnik H, Groten T, Kusenbach G, Posselt HG. Long-term fungal cultures from sputum of patients with cystic fibrosis. Mycoses 1991;34:373-376.
48. Hadley S, KarchmerAW. Fungal infections in solid organ transplant recipients. Infect Dis Clin of North America 1995;9:1045-1074.
49. Herbrecht R. The changing epidemiology of fungal infections: Are the lipid-forms of amphotericin B an advance? Europ J Haematol 1996;Supplement 57:12-7.
50. Hirst GL, Illand M. Automated fluorescent detection of microsatellite instability. Molec Biotech 2001;17:239-47.
51. Horn J, Barlett J. Infectious complications following heart transplantation In: Baumgartner, W., Reitz, B., & Achuff, S. (eds) Heart and Heart-Lung Transplantation. 1990 Philadephia: WB Saunders, p 211.
52. Huang YC, Lin TY, Leu HS, Peng HL, Wu JH, Chang HY. Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: Clinical implications and genotyping analysis. Infection 1999;27: 97-102.
53. Jabado N, Casanova JL, Haddad E, et al. Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin Infect Dis 1998;27:1437-41.
54. Jantunen E, Ruutu P, Niskanen L, et al. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients. Bone Marrow Transplant 1997;19:801-8.
55. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;20:1526-30.
56. Joly S, Pujol C, Schroppel K, Soll DR. Development of two species-specific fingerprinting probes for broad computer-assisted epidemiological studies of Candida tropicalis. J Clin Microb 1996;34: 3063-71.
57. Kanj SS, Welty-Wolf K, Madden J, et al. Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. Medicine (Baltimore) 1996;75:142-56.
58. Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: Results of a population-based active surveillance. Clin Infect Dis 1999;29:1164-70.
59. Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000;30 (Suppl 1):S5-S14.
60. Kappe R, Levitz S, Harrison TS, Ruhnke M, Ampel NM, Just-Nubling G. Recent advances in cryptococcosis, candidiasis and coccidioidomycosis complicating HIV infection. Med Mycol 1998;36 (Suppl 1):207-15.
61. Karabinis A, Hill C, Leclercq B, Tancrede C, Baume D, Andremont A. Risk factors for candidemia in cancer patients: A case-control study. J Clin Microb 1988;26:429-32.
62. Kirkland TN, Fierer J. Coccidioidomycosis: A reemerging infectious disease. Emerg Infect Dis 1996;2:192-9.
63. Klein BS, Vergeront JM, Davis JP. Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis. Semin Resp Infect 1986;1:29-39.
64. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: Frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;11:379-90.
65. Konduracka E. Opportunistic fungal infections in patients treated with heart transplantation - Own centre experiences. Ann Transpl 1998;3:21-4.
66. Kramer MR, Marshall SE, Starnes VA, Gamberg P, Amitai Z, Theodore J. Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch Int Med 1993;153:2010-6.
67. Krcmery V, Krupova I, Denning DW. Invasive yeast infections other than Candida spp. in acute leukemia. J Hosp Infect 1999;41:181-94.
68. Kwon-Chung KJ, Sorrell TC, Dromer F, Fung E, Levitz SM. Cryptococcosis: Clinical and biological aspects. Med Mycol 2000;38 Suppl 1:205-13.
69. Lamy T, Bernard M, Courtois A, et al. Prophylactic use of itraconazole for the prevention of invasive pulmonary aspergillosis in high risk neutropenic patients. Leukemia and Lymphoma 1998;30:163-74.
70. Lass-Florl C, Kofler G, Kropshofer G, et al. In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 1998;42: 497-502.
71. Magee BB, D'Souza TM, Magee PT. Strain and species identification by restriction fragment length polymorphisms in the ribosomal DNA repeat of Candida species. J Bacter 1987;169:1639-43.
72. Manuel RJ, Kibbler CC. The epidemiology and prevention of invasive aspergillosis. J Hosp Infect 1998;39:95-109.
73. McAlpin CE, Mannarelli B. Construction and characterization of a DNA probe for distinguishing strains of Aspergillus flavus. Appl Environ Microbiol 1995;61:1068-72.
74. McCullough MJ, Clemons KV, Del Palacio A, Stevens DA. Epidemiology of Candida albicans isolates from heroin addicts analysed by DNA typing. Med Mycol 1998;36:213-7 (erratum in Med Mycol 1998;36:441).
75. Metzgar D, van Belkum A, Field D, Haubrich R, Wills C. Random amplification of polymorphic DNA and microsatellite genotyping of pre- and posttreatment isolates of Candida spp. from human immunodeficiency virus-infected patients on different fluconazole regimens. J Clin Microb 1998;36:2308-13.
76. Meunier-Carpentier F. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections. Am J Med 1984;76:652-6.
77. Meyer W, Latouche GN, Daniel HM, et al. Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting. Electrophoresis 1997;18:1548-59.
78. Meyer W, Mitchell TG. Polymerase chain reaction fingerprinting in fungi using single primers specific to minisatellites and simple repetitive DNA sequences: Strain variation in Cryptococcus neoformans. Electrophoresis 1995;16:1648-56.
79. Meyers JD. Fungal infections in bone marrow transplant patients. Semin Oncol 1990;17 (Suppl 6):10-3.
80. Narang A, Agrawal PB, Chakrabarti A, Kumar P. Epidemiology of systemic candidiasis in a tertiary care neonatal unit. J Trop Ped 1998;44:104-8.
81. Nguyen MH, Peacock JEJ, Morris AJ, et al. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996;100:617-23.
82. Pan S, Cole GT. Electrophoretic karyotypes of clinical isolates of Coccidioides immitis. Infect Immun 1992;60:4872-80.
83. Pannuti CS, Gingrich RD, Pfaller MA, Wenzel RP. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: A 9-year study. J Clin Oncol 1991;9:77-84.
84. Parisi A, Sacchi P, Filice G. Treatment of cryptococcal meningitis in liver transplantation (letter). Infect 1998;26:314-6.
85. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993;16:677-88.
86. Perfect JR, Schell WA. The new fungal opportunists are coming. Clin Infect Dis 1996;22 (Suppl 2):S112-S118.
87. Petri MG, Konig J, Moecke HP, et al. Epidemiology of invasive mycosis in ICU patients: A prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intens C Med 1997;23: 317-25.
88. Pfaller MA. Epidemiology and control of fungal infections. Clin Infect Dis 1994;19 (Suppl 1):S8-S13.
89. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998;30:121-9.
90. Philpott-Howard J. Prevention of fungal infections in hematology patients. Infect Contr Hosp Epidem 1996;17:545-51.
91. Pittet D, Mourouga P, Perneger TV. Compliance with handwashing in a teaching hospital. Ann Intern Med 1999;130:126-30.
92. Rangel-Frausto MS, Wiblin T, Blumberg HM, et al. National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999;29:253-8.
93. Redkar RJ, Dube MP, McCleskey FK, Rinaldi MG, Del Vecchio VG. DNA fingerprinting of Candida rugosa via repetitive sequence-based PCR. J Clin Microb 1996;34:1677-81.
94. Reiss E, Tanaka K, Bruker G, et al. Molecular diagnosis and epidemiology of fungal infections. Med Mycol 1998;36 (Suppl 1):249-257.
95. Ribaud P, Chastang C, Latge JP, et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 1999;28:322-30.
96. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in coronary care units in the United States. National Nosocomial Infections Surveillance System. Am Card 1998;82:789-93.
97. Richet HM, Andremont A, Tancrede C, Pico JL, Jarvis WR. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Inf Dis 1991;13:211-5.
98. Rinaldi MG. Epidemiology of mycoses in the HIV-infected patient: Clinical aspects. Internat J Antimicrob Ag 1996;6:131-4.
99. Rubin R. Infection in the organ transplant recipients In: Rubin, R. & Young, L. (eds) Clinical Approach to Infection in the Compromised Host. New York:Plenum Press 1994; p 629-705.
100. Sallah S. Hepatosplenic candidiasis in patients with acute leukemia: Increasingly encountered complication. Anticancer Research 1999;19:757-60.
101. Samaranayake YH, Samaranayake LP. Candida krusei: Biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. J Med Microb 1994;41:295-310.
102. Scherer S, Stevens DA. Application of DNA typing methods to epidemiology and taxonomy of Candida species. J Clin Microb 1987; 25:675-9.
103. Schmid J, Voss E, Soll DR. Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3. J Clin Microb 1990;28:1236-43.
104. Schwartz RS, Mackintosh FR, Halpern J, Schrier SL, Greenberg PL. Multivariate analysis of factors associated with outcome of treatment for adults with acute myelogenous leukemia. Cancer 1984;54: 1672-81.
105. Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM. Aspergillus nidulans infection in chronic granulomatous disease. Medicine 1998;77:345-54.
106. Singh N, Gayowski T, Wagener MM, Doyle H, Marino IR. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clin Infect Dis 1997;24:179-84.
107. Sobel JD. Practice guidelines for the treatment of fungal infections. Clin Infect Dis 2000;30:652.
108. Spitzer ED, Lasker BA, Travis SJ, Kobayashi GS, Medoff G. Use of mitochondrial and ribosomal DNA polymorphisms to classify clinical and soil isolates of Histoplasma capsulatum. Infect Immun 1989;57: 1409-12.
109. Steffan P, Vazquez JA, Boikov D, Xu C, Sobel JD, Akins RA. Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates. J Clin Microb 1997;35:2031-9.
110. Still JMJ, Belcher K, Law EJ. Management of Candida septicaemia in a regional burn unit. Burns 1995;21:594-6.
111. Sullivan DJ, Henman MC, Moran GP, et al. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J Med Microb 1996;44:399-408.
112. van Gelderen de Komaid A, Duran E, Borges de Kestelman I. Histoplasmosis and paracoccidioidomycosis in northwestern Argentina III. Epidemiological survey in Vipos, La Toma, and Choromoro - Trancas, Tucuman, Argentina. Europ J Epidem 1999;15:383-388.
113. Van Trigt P. Complication-specific management of postoperative care after cardiac transplantation. Coron Art Dis 1992;3:767.
114. Vazquez JA, Sanchez V, Dmuchowski C, Dembry LM, Sobel JD, Zervos MJ. Nosocomial acquisition of Candida albicans: An epidemiologic study. J Infect Dis 1993;168:195-201.
115. Vincent JL, Anaissie E, Bruining H, et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Medicine 1998;24:206-16.
116. Viscoli C, Girmenia C, Marinus A, et al. Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999;28: 1071-9.
117. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation: An analysis of 284 patients. Hepatology 1995;21:1328-36.
118. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997;175:1459-66.
119. Ward S, Heyneman L, Lee MJ, Leung AN, Hansell DM, Muller NL. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. Am J Roentgen 1999;173:937-42.
120. Weems JJJ. Candida parapsilosis: Epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 1992;14:756-66.
121. Welbel SF, McNeil MM, Kuykendall RJ, et al. Candida parapsilosis bloodstream infections in neonatal intensive care unit patients: Epidemiologic and laboratory confirmation of a common source outbreak. Ped Infect Dis J 1996;15:998-1002.
122. Welsh J, McClelland M. Fingerprinting genomes using PCR with arbitrary primers. Nucl Ac Res 1990;18:7213-8.
123. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989;149:2349-53.
124. White MH. The contribution of fluconazole to the changing epidemiology of invasive candidal infections (editorial). Clin Infect Dis 1997;24:1129-30.
125. Wiesenfeld HC, Berg SR, Sweet RL. Torulopsis glabrata pelvic abscess and fungemia. Obst Gynecol 1994;83:887-9.
126. Wiley JM, Smith N, Leventhal BG, et al. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: A multivariate analysis of risk factors. J Clin Oncol 1990;8:280-6.
127. Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, Beney J. The direct cost and incidence of systemic fungal infections. Value. Health 2002;5:26-34.
128. Woods JP, Kersulyte D, Goldman WE, Berg DE. Fast DNA isolation from Histoplasma capsulatum: Methodology for arbitrary primer polymerase chain reaction-based epidemiological and clinical studies. J Clin Microb 1993;31:463-4.
129. Woods ML, MacGinley R, Eisen DP, Allworth AM. HIV combination therapy: Partial immune restitution unmasking latent cryptococcal infection. AIDS1998;12:1491-4.
130. Yamamoto Y, Kohno S, Koga H, et al. Random amplified polymorphic DNA analysis of clinically and environmentally isolated Cryptococcus neoformans in Nagasaki,. J Clin Microb 1995;33:3328-3332.
131. Yamazaki T, Kume H, Murase S, Yamashita E, Arisawa M. Epidemiology of visceral mycoses: Analysis of data in annual of the pathological autopsy cases in Japan. J Clin Microb 1999;37:1732-8.
132. Yates-Siilata KE, Sander DM, Keath EJ. Genetic diversity in clinical isolates of the dimorphic fungus Blastomyces dermatitidis detected by a PCR-based random amplified polymorphic DNA assay. J Clin Microb 1995;33:2171-5.
133. Zeng S, Wu LC, Lehmann PF. Random amplified polymorphic DNA analysis of culture collection strains of Candida species. J Med Veter Mycol 1996;34:293-7.